Mouse anti-Human GJC2 Monoclonal Antibody | anti-GJC2 antibody
GJC2, NT (GJC2, GJA12, Gap junction gamma-2 protein, Connexin-46.6, Connexin-47, Gap junction alpha-12 protein)
Purified by ammonium sulfate precipitation.
Purified by ammonium sulfate precipitation.
Dilution: ELISA: 1:1,000
Western Blot: 1:100~500
NCBI and Uniprot Product Information
NCBI Description
This gene encodes a gap junction protein. Gap junction proteins are members of a large family of homologous connexins and comprise 4 transmembrane, 2 extracellular, and 3 cytoplasmic domains. This gene plays a key role in central myelination and is involved in peripheral myelination in humans. Defects in this gene are the cause of autosomal recessive Pelizaeus-Merzbacher-like disease-1. [provided by RefSeq, Jul 2008]
Uniprot Description
Function: One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. May play a role in myelination in central and peripheral nervous systems. Ref.5
Subunit structure: A connexon is composed of a hexamer of connexins. Interacts with TJP1
By similarity.
Subcellular location: Cell membrane; Multi-pass membrane protein. Cell junction › gap junction.
Tissue specificity: Expressed in central nervous system, in sciatic nerve and sural nerve. Also detected in skeletal muscles. Ref.5
Involvement in disease: Leukodystrophy, hypomyelinating, 2 (HLD2) [MIM:608804]: An autosomal recessive hypomyelinating leukodystrophy with symptoms of Pelizaeus-Merzbacher disease. Clinically characterized by nystagmus, impaired motor development, ataxia, choreoathetotic movements, dysarthria, and progressive spasticity.Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.5Spastic paraplegia 44, autosomal recessive (SPG44) [MIM:613206]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG39 is associated with a motor axonopathy affecting upper and lower limbs and resulting in progressive wasting of distal upper and lower extremity muscles.Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.5 Ref.7Lymphedema, hereditary, 1C (LMPH1C) [MIM:613480]: A chronic disabling condition which results in swelling of the extremities due to altered lymphatic flow. Patients with lymphedema suffer from recurrent local infections and physical impairment.Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.5 Ref.8
Sequence similarities: Belongs to the connexin family. Gamma-type subfamily.
Caution: It is uncertain whether Met-1 or Met-4 is the initiator.
Sequence caution: The sequence AAB94511.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended.The sequence AAH35840.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended.
Research Articles on GJC2
Similar Products
Product Notes
The GJC2 gjc2 (Catalog #AAA648279) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The GJC2, NT (GJC2, GJA12, Gap junction gamma-2 protein, Connexin-46.6, Connexin-47, Gap junction alpha-12 protein) reacts with Human and may cross-react with other species as described in the data sheet. AAA Biotech's GJC2 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB). Suitable for use in Western Blot, ELISA. Dilution: ELISA: 1:1,000 Western Blot: 1:100~500. Researchers should empirically determine the suitability of the GJC2 gjc2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "GJC2, Monoclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.